Dark

Check out our Level2View

EVFM
EVOFEM BIOSCIENCE INC
stock OTC

Inactive

Nov 7, 2022

0.0888USD-81.430%(-0.3894)53,992,633

Pre-market

0.00USD-100.000%(-0.62)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 19, 2022

09:12AM EST Evofem Biosciences Sees Q4 2021 Net Product Sales $3.5M Benzinga

09:03AM EST Evofem Biosciences Reports 81% Increase In Phexxi Units Dispensed RTTNews

09:03AM EST Evofem Biosciences Announces Record Net Sales and Phexxi Prescriptions in Q4 PR Newswire

Jan 12, 2022

12:51PM EST Stifel Issues Mid-Day Note On Evofem, Says Updated Federal Guidelines For FDA-Approved Contraceptives, $0 Co Pay Is 'A Critical Logistical Win...' Benzinga

06:01AM EST Phexxi Access to Expand under New Government Guidance Stating Insurers Must PR Newswire

Jan 4, 2022

07:01AM EST Evofem Biosciences to Present at H.C. Wainwright BioConnect Conference PR Newswire

Dec 16, 2021

07:20AM EST Evofem Biosciences And Orion Biotechnology Launch Collaboration To Develop MPT Product Candidate To Include HIV Prevention Benzinga

07:14AM EST Evofem Biosciences And Orion Biotechnology Collaborate To Develop MPT Product Candidate To Include HIV Prevention RTTNews

07:01AM EST Evofem Biosciences and Orion Biotechnology Launch Collaboration to Develop MPT PR Newswire

Dec 9, 2021

09:46PM EST Evofem Biosciences Says Total Monthly Prescriptions Of Phexxi Are On Track To Surpass 30,000 In Q4, Up 70% From Q3 Benzinga

08:02AM EST Evofem Biosciences Expects Record High Phexxi Prescriptions and Strong Net PR Newswire

Dec 8, 2021

06:31AM EST Evofem Biosciences to Adjourn Special Meeting of Stockholders on December 8, PR Newswire

Nov 30, 2021

04:44PM EST Evofem Biosciences Announces Successful Type C Meeting With FDA For STI Prevention Product Candidate In Which Agreement Was Reached On Submission Strategy For EV0100 Benzinga

08:12AM EST Evofem Biosciences Reports Successful Type C Meeting With FDA For STI Prevention Product Candidate RTTNews

08:03AM EST Evofem Biosciences Announces Successful Type C Meeting with FDA for STI PR Newswire

Nov 22, 2021

06:53AM EST Evofem Biosciences Extends the Net Sales Covenant of its 2020 Debt to 2023 Benzinga

06:51AM EST Evofem Biosciences Says Successfully Extends Cumulative Net Sales Covenant Timing To June 30, 2023 RTTNews

06:50AM EST Evofem Biosciences Successfully Extends Cumulative Net Sales Covenant Timing to PR Newswire

Nov 19, 2021

07:01AM EST Evofem Biosciences to Participate in Piper Sandler 33rd Annual Healthcare PR Newswire

Nov 16, 2021

09:43AM EST HC Wainwright & Co. Maintains Buy on Evofem Biosciences, Lowers Price Target to $2 Benzinga

Nov 15, 2021

04:08PM EST Evofem Biosciences Q3 EPS $(0.48) Misses $(0.29) Estimate, Sales $1.71M Up From $278.00K YoY Benzinga

04:00PM EST Evofem Biosciences Reports Third Quarter 2021 Financial Results and Provides PR Newswire

11:07AM EST Earnings Scheduled For November 15, 2021 Benzinga

10:37AM EST The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More Benzinga

Nov 12, 2021

10:57AM EST Earnings Preview For Evofem Biosciences Benzinga

Nov 10, 2021

07:41AM EST Evofem Biosciences Announces Regulatory Submission In Mexico For Its Hormone-Free Contraceptive Benzinga

07:14AM EST Evofem Biosciences Announces Regulatory Submission In Mexico For Hormone-Free Contraceptive RTTNews

07:02AM EST Evofem Biosciences Announces Regulatory Submission in Mexico for Its PR Newswire

Nov 4, 2021

08:01AM EDT Evofem Biosciences to Participate in Stifel 2021 Virtual Healthcare Conference PR Newswire

Oct 28, 2021

08:02AM EDT Evofem Biosciences to Report Third Quarter 2021 Results and Provide Corporate PR Newswire

Oct 21, 2021

12:11PM EDT HC Wainwright & Co. Maintains Buy on Evofem Biosciences, Lowers Price Target to $2.5 Benzinga

Oct 20, 2021

08:02AM EDT "House Rules" Delivers Strong Initial Results and Drives Phexxi Growth PR Newswire

Oct 14, 2021

11:18AM EDT Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021 Benzinga

06:01AM EDT Morgan Stanley Downgrades Evofem Biosciences to Underweight, Announces $0.8 Price Target Benzinga

Oct 12, 2021

06:32AM EDT Evofem Biosciences Announces $10 Million Registered Direct Offering of Series B PR Newswire

Oct 8, 2021

08:01AM EDT Evofem Biosciences Commends House of Representatives Leaders for Action to PR Newswire

Sep 30, 2021

08:15AM EDT Evofem Biosciences To Present At LD Micro Investor Conference On October 12 Benzinga

Sep 27, 2021

08:16AM EDT Evofem : Manuscript On Variability Of Contraceptive Trial Design And Impact On Efficacy Outcomes Published RTTNews

08:06AM EDT Evofem Biosciences Highlights Publication On 'the variability of contraceptive clinical trial design and its impact on efficacy outcomes' In Peer-Reviewed Journal Advances In Therapy Benzinga

08:02AM EDT Evofem Biosciences Announces Publication in Peer-Reviewed Journal Advances in PR Newswire

Sep 22, 2021

12:59PM EDT Evofem Biosciences's Return On Capital Employed Insights Benzinga

Sep 16, 2021

08:12AM EDT Evofem Biosciences To Present Seven Abstracts On Vaginal PH Modulator RTTNews

08:01AM EDT Seven Abstracts to be Presented on Evofem Biosciences' Vaginal pH Modulator PR Newswire

Sep 9, 2021

10:52AM EDT 'Schitt's Creek' Star Annie Murphy Headlines New Campaign For Phexxi Contraceptive Benzinga

08:02AM EDT Emmy(r) Award Winner Annie Murphy Partners with Evofem Biosciences to Talk Sex, PR Newswire

Sep 1, 2021

08:02AM EDT Evofem Biosciences to Participate in Investor Conferences PR Newswire

Aug 18, 2021

07:38AM EDT The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline Benzinga

Aug 17, 2021

08:28AM EDT The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga

Aug 12, 2021

07:54AM EDT Morgan Stanley Maintains Equal-Weight on Evofem Biosciences, Lowers Price Target to $1 Benzinga

Aug 11, 2021

05:02PM EDT Evofem Biosciences: Q2 Earnings Insights Benzinga

04:46PM EDT Evofem Biosciences Q2 EPS $(0.27) May Not Compare To $(0.41) Estimate Benzinga

04:28PM EDT Evofem Biosciences Reports Second Quarter 2021 Financial Results and Provides PR Newswire

09:06AM EDT Earnings Scheduled For August 11, 2021 Benzinga

08:14AM EDT The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering Benzinga

04:27AM EDT Earnings Scheduled For August 11, 2021 Benzinga

Aug 9, 2021

11:07AM EDT The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight Benzinga

Jul 28, 2021

08:00AM EDT Evofem Biosciences to Report Second Quarter 2021 Results and Provide Corporate PR Newswire

Jul 14, 2021

08:05AM EDT Early Look at Second Quarter Metrics for Phexxi(r) Reveals Strong Growth PR Newswire

Jun 7, 2021

07:48AM EDT 10 Biggest Price Target Changes For Monday Benzinga

06:22AM EDT HC Wainwright & Co. Maintains Buy on Evofem Biosciences, Lowers Price Target to $4 Benzinga

Jun 1, 2021

09:03AM EDT Evofem Biosciences to Present at Jefferies Virtual Healthcare Conference 2021 PR Newswire

May 27, 2021

08:24AM EDT The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs Benzinga

May 25, 2021

08:01AM EDT Evofem Biosciences to Present at LD Micro Invitational XI on Tuesday, June 8, PR Newswire

May 21, 2021

06:53AM EDT Evofem Biosciences Reports Closing Of $50 Mln Public Offering RTTNews

06:50AM EDT Evofem Biosciences Announces Closing of $50 Million Public Offering PR Newswire

May 19, 2021

07:30AM EDT The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics Benzinga

May 18, 2021

02:38PM EDT Mid-Afternoon Market Update: Nasdaq Turns Negative; Ultralife Shares Spike Higher Benzinga

12:18PM EDT Mid-Day Market Update: TOMI Environmental Solutions Falls After Q1 Results; Agenus Shares Jump Benzinga

09:06AM EDT Evofem Biosciences Stock Plunges On Raising $50M Via Equity At 22% Discount Benzinga

07:44AM EDT The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO Benzinga

May 17, 2021

11:16PM EDT Evofem Biosciences Announces Pricing Of $50 Mln Public Offering RTTNews

11:03PM EDT Evofem Biosciences Announces Pricing of $50 Million Public Offering PR Newswire

04:05PM EDT Evofem Biosciences Announces Proposed Public Offering PR Newswire

04:05PM EDT Evofem Reports Offering Of Common Stock, No Size Disclosed Benzinga

09:39AM EDT Evofem To Present New Data On EVO100 For The Prevention Of Chlamydia And Gonorrhea In Women RTTNews

08:02AM EDT New Data on EVO100 for the Prevention of Chlamydia and Gonorrhea in Women to be PR Newswire

May 12, 2021

04:19PM EDT Fulcrum Therapeutics, Evofem Biosciences Drug Candidates Receive FDA Fast Track Designation Benzinga

10:00AM EDT Biopharmaceutical company Evofem Biosciences, Inc. (EVFM) announced Wednesday that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for EVO100 for the prevention of urogenital gonorrhea in women. RTTNews

09:08AM EDT Evofem Biosciences Secures Fast Track Designation From FDA For EVO100 For Prevention Of Gonorrhea In Women RTTNews

09:02AM EDT Evofem Biosciences Receives Fast Track Designation for EVO100 for Prevention of PR Newswire

08:57AM EDT The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron Benzinga

May 11, 2021

07:54AM EDT The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings Benzinga

May 7, 2021

07:40AM EDT The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs Benzinga

May 6, 2021

04:41PM EDT Evofem Biosciences Q1 EPS $(0.56) Misses $(0.49) Estimate, Sales $1.10M Miss $1.63M Estimate Benzinga

04:02PM EDT Evofem Biosciences Reports First Quarter 2021 Financial Results and Provides PR Newswire

07:49AM EDT The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom Benzinga

04:17AM EDT Earnings Scheduled For May 6, 2021 Benzinga

May 5, 2021

07:43AM EDT The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues Benzinga

Apr 28, 2021

11:01AM EDT Evofem Biosciences Announces Presentation of Two New Phexxi Data Sets at the PR Newswire

Apr 22, 2021

08:09AM EDT The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs Benzinga

08:02AM EDT Evofem Biosciences to Report First Quarter 2021 Results and Provide Corporate PR Newswire

Apr 21, 2021

08:38AM EDT Evofem Biosciences Says To Deliver Keynote Address, Present 2 Phexxi Data Sets At NCODA 2021 National Spring Forum Benzinga

08:01AM EDT Evofem Biosciences to Deliver Keynote Address and Present Two Phexxi Data Sets PR Newswire

07:31AM EDT The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue Benzinga

Apr 16, 2021

08:01AM EDT The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs Benzinga

Apr 14, 2021

07:51AM EDT The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead Benzinga

Mar 31, 2021

07:41AM EDT The Daily Biotech Pulse: Pfizer Vaccine 100% Effective In Adolescents, Equillium Readout, Amgen Goes Shopping, Achilles IPO Benzinga

Mar 29, 2021

04:06PM EDT Evofem Biosciences Announces Closing of Public Offering of Common Stock PR Newswire

Mar 26, 2021

07:28AM EDT The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs Benzinga

Mar 25, 2021

02:39PM EDT Mid-Afternoon Market Update: Dow Rises 75 Points; Rite Aid Shares Plummet Benzinga

12:08PM EDT Mid-Day Market Update: Crude Oil Down Over 4%; Cellect Biotechnology Shares Surge Benzinga

10:12AM EDT Mid-Morning Market Update: Markets Mostly Lower; Darden Restaurants Tops Q3 Views Benzinga

07:58AM EDT The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut Benzinga

Mar 24, 2021

10:19PM EDT Evofem Biosciences Prices Underwritten Public Offering Of 17.14 Mln Shares At $1.75/shr RTTNews

10:01PM EDT Evofem Biosciences Announces Pricing of $30 Million Public Offering of Common PR Newswire

04:01PM EDT Evofem Biosciences Announces Proposed $30M Public Offering Of Common Stock Benzinga

04:01PM EDT Evofem Biosciences Announces Proposed Public Offering of Common Stock PR Newswire

Mar 17, 2021

08:02AM EDT Evofem Biosciences' DTC Campaign "Get Phexxi" Delivers Strong Initial Impact PR Newswire

Mar 16, 2021

08:29AM EDT Evofem Biosciences Highlights Publication In American Journal Of Obstetrics And Gynecology Of AMPREVENCE Study Of EVO100 For Chlamydia And Gonorrhea Prevention Benzinga

08:12AM EDT Evofem Biosciences Publishes Pivotal Manuscript From AMPREVENCE Trial In American Journal Of Obstetrics And Gynecology RTTNews

08:02AM EDT Gynecology of AMPREVENCE Study of EVO100 for Chlamydia and Gonorrhea Prevention PR Newswire

Mar 10, 2021

05:49AM EST Evofem Biosciences CEO Saundra Pelletier Reported Purchase of 45,249 Shares @ Avg Price of $2.28/Share in Form 4 Filing on Tuesday Benzinga

Mar 8, 2021

06:17AM EST HC Wainwright & Co. Maintains Buy on Evofem Biosciences, Lowers Price Target to $7 Benzinga

Mar 5, 2021

02:39PM EST Mid-Afternoon Market Update: Nasdaq Surges 150 Points; Calyxt Shares Slide Benzinga

12:06PM EST Mid-Day Market Update: Dow Tumbles Over 100 Points; Sify Technologies Shares Spike Higher Benzinga

10:38AM EST ROCE Insights For Evofem Biosciences Benzinga

10:10AM EST Mid-Morning Market Update: Markets Mixed; Big Lots Earnings Top Views Benzinga

Mar 4, 2021

05:28PM EST Evofem Biosciences: Q4 Earnings Insights Benzinga

04:06PM EST Evofem Biosciences Q4 Loss/share $0.50 Vs. Loss $0.27 Year Ago RTTNews

04:00PM EST Evofem Biosciences Q4 EPS $(0.50) Misses $(0.36) Estimate Benzinga

04:00PM EST Evofem Biosciences Reports Fourth Quarter and Year-End 2020 Financial Results PR Newswire

08:12AM EST The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company Benzinga

04:07AM EST Earnings Scheduled For March 4, 2021 Benzinga

Feb 27, 2021

09:04PM EST The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings Benzinga

Feb 23, 2021

08:01AM EST Evofem Biosciences to Present at H.C. Wainwright Global Life Sciences Conference PR Newswire

Feb 18, 2021

08:02AM EST Evofem Biosciences to Report Fourth Quarter and Year-End 2020 Results and PR Newswire

Feb 16, 2021

08:01AM EST Evofem Biosciences Launches U.S. Direct-to-Consumer Campaign to Accelerate PR Newswire

Feb 4, 2021

09:05AM EST Evofem Biosciences and NCODA Announce Collaboration to Educate Oncology Community about Phexxi, A Non-Hormonal Birth Control Option for Women with Cancer Benzinga

09:01AM EST Community about Phexxi(r), A Non-Hormonal Birth Control Option for Women with Cancer PR Newswire

Jan 12, 2021

09:05AM EST Evofem Biosciences Wins Business Intelligence Group's BIG Innovation Award 2021 PR Newswire

Dec 22, 2020

07:01AM EST Evofem Biosciences to Participate in Medicaid National Drug Rebate Program for PR Newswire

Dec 21, 2020

09:01AM EST Evofem Biosciences to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual PR Newswire

Dec 17, 2020

07:43AM EST Evofem Biosciences Updates On Pivotal Phase 3 Trial Of EVO100 For Prevention Of Chlamydia And Gonorrhea RTTNews

07:02AM EST Evofem Biosciences Reports Its Pivotal Phase 3 Trial Of EVOGUARD Remains Firmly On Schedule Benzinga

07:01AM EST Evofem Biosciences Provides Update on Pivotal Phase 3 Trial of EVO100 for PR Newswire

Dec 11, 2020

08:04AM EST Evofem Biosciences Announces Orange Book Listing Of Two US Patents For Phexxi Benzinga

08:01AM EST Evofem Biosciences Announces Orange Book Listing of Two U.S. Patents for PR Newswire

Dec 3, 2020

07:02AM EST The U.S. Department of Veterans Affairs Awards Contract to Evofem Biosciences PR Newswire

Nov 20, 2020

08:31AM EST Evofem Biosciences to Participate in Piper Sandler 32nd Annual Virtual PR Newswire

Nov 12, 2020

08:31AM EST Evofem Biosciences to Present at Stifel Virtual Healthcare Conference PR Newswire

Nov 10, 2020

09:57AM EST Evofem Biosciences shares are trading higher after the company reported better-than-expected Q3 EPS results. Benzinga

Nov 9, 2020

04:13PM EST Evofem Biosciences Q3 EPS $(0.37) Beats $(0.44) Estimate, Sales $278.00K May Not Compare To $1.72M Estimate Benzinga

04:02PM EST Evofem Biosciences Reports Third Quarter 2020 Financial Results and Provides PR Newswire

04:13AM EST Earnings Scheduled For November 9, 2020 Benzinga

Nov 8, 2020

03:58PM EST The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions Benzinga

12:47PM EST The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs Benzinga

Oct 27, 2020

08:01AM EDT Evofem Biosciences to Report Third Quarter 2020 Results and Provide Corporate PR Newswire

Oct 26, 2020

09:01AM EDT Evofem Biosciences to Participate in Virtual Investor KOL Roundtable PR Newswire

Oct 20, 2020

08:13AM EDT Evofem Biosciences Announces First Patient Enrolled in Pivotal Phase 3 Trial of EVO100 for Prevention of Chlamydia and Gonorrhea Benzinga

08:13AM EDT Evofem Says First Patient Enrolled In Pivotal Phase 3 Trial Of EVO100 For Prevention Of Chlamydia And Gonorrhea RTTNews

08:00AM EDT Evofem Biosciences Announces First Patient Enrolled in Pivotal Phase 3 Trial of PR Newswire

Oct 15, 2020

08:27AM EDT Evofem Biosciences Announces That It Secured $25M In Strategic Investment From Adjuvant Capital Benzinga

08:03AM EDT Evofem Biosciences Sells $25 Mln Of Unsecured Convertible Promissory Notes To Funds Affiliated With Adjuvant Capital, LP RTTNews

08:02AM EDT Evofem Biosciences Secures $25 Million Strategic Investment from Adjuvant PR Newswire

Oct 8, 2020

10:15AM EDT Evofem Biosciences Option Alert: Jan 15 $5 Calls Sweep (49) near the Ask: 458 @ $0.494 vs 3904 OI; Earnings 11/4 After Close [est] Ref=$2.87 Benzinga

Oct 7, 2020

08:01AM EDT Evofem Biosciences Announces Presentations on Phexxi and EVO100 at Key Medical PR Newswire

Oct 2, 2020

10:39AM EDT Benzinga's Top Upgrades, Downgrades For October 2, 2020 Benzinga

06:03AM EDT Stifel Initiates Coverage On Evofem Biosciences with Buy Rating, Announces Price Target of $5 Benzinga

Sep 16, 2020

12:13PM EDT Evofem Biosciences Announces Updated Date and Time for Fireside Chat at Cantor PR Newswire

Sep 14, 2020

09:13AM EDT Evofem Biosciences To Present Data At 2020 STD Prevention Virtual Conference From Phase 2b Trial Of EVO100 For Prevention Of Chlamydia And Gonorrhea In Women Benzinga

09:01AM EDT Conference from Phase 2b Trial of EVO100 for Prevention of Chlamydia and Gonorrhea in Women PR Newswire

Sep 11, 2020

03:07PM EDT Mid-Afternoon Market Update: Nasdaq Drops Over 100 Points; A-Mark Precious Metals Shares Spike Higher Benzinga

12:04PM EDT Mid-Day Market Update: Zumiez Surges After Q2 Results; Amyris Shares Slide Benzinga

10:27AM EDT Return On Capital Employed Overview: Evofem Biosciences Benzinga

10:21AM EDT Mid-Morning Market Update: Markets Gain; Kroger Beats Q2 Estimates Benzinga

Sep 8, 2020

08:38AM EDT Evofem Biosciences Announces U.S. Commercial Launch Of Phexxi On-Demand Prescription Contraceptive Vaginal Gel RTTNews

08:33AM EDT Evofem Biosciences Highlights US Commercial Launch Of Phexxi Benzinga

08:31AM EDT citric acid and potassium bitartrate), the First and Only Non-Hormonal, On-Demand Prescription Contraceptive Vaginal Gel PR Newswire

Aug 31, 2020

09:01AM EDT Evofem Biosciences to Participate in Four Upcoming Investor Conferences PR Newswire

Aug 21, 2020

06:00PM EDT Evofem Biosciences Reports Inducement Grants Under Nasdaq Listing Rule PR Newswire

Aug 20, 2020

09:51AM EDT Benzinga's Top Upgrades, Downgrades For August 20, 2020 Benzinga

06:30AM EDT Morgan Stanley Initiates Coverage On Evofem Biosciences with Equal-Weight Rating Benzinga

Aug 4, 2020

08:12AM EDT Evofem Biosciences Reaffirms FY 2020 Guidance Benzinga

08:12AM EDT Evofem Biosciences Q2 GAAP EPS $(0.91) Misses $(0.37) Estimate Benzinga

08:11AM EDT Evofem Q2 Loss Attributable To Stockholders $52.7 Mln Or $0.91/Shr Vs Loss Of $35.5 Mln Or $0.97/Shr Last Year RTTNews

08:01AM EDT Evofem Biosciences Reports Second Quarter 2020 Financial Results and Provides PR Newswire

05:19AM EDT Earnings Scheduled For August 4, 2020 Benzinga

Aug 3, 2020

08:31AM EDT Evofem Biosciences' CEO Saundra Pelletier Named to PharmaVOICE100 - The Most PR Newswire

Jul 23, 2020

08:31AM EDT Evofem Biosciences to Report Second Quarter 2020 Results and Provide Corporate PR Newswire

Jul 15, 2020

08:33AM EDT Evofem Biosciences Highlights Peer-Reviewed Publication Of Pivotal Phase 3 AMPOWER Study Results For Phexxi (lactic acid, citric acid and potassium bitartrate) In Contraception Benzinga

08:31AM EDT AMPOWER Study Results For Phexxi(tm) (lactic acid, citric acid and potassium bitartrate) in Contraception PR Newswire

Share